HTB

2024

Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan

WHO toolkit to strengthen engagement of health workers in emergency responses

HTB news: i-Base changes during 2024

Bipolar disorder in people living with HIV

Mpox breakthrough cases after two doses of the MVA-BN vaccine

Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic

Future meetings and webinars 2024/2025

Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA

Helsinki Declaration: 2024 edition upholds ethical access to treatment

Lack of tecovirimat activity against mpox clade 1

Efficacy of MVA-BN vaccine: systematic review

Kidney transplants from HIV positive donors to HIV recipients

US NIAID updates HIV guide to person-centred language

Long COVID essentials: link to online resources

Urgency of planning broad vaccine-like access to lenacapavir PrEP globally

Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound

Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study

HIVR4P 2024: Context of PrEP in Latin America

HIVR4P 2024: Introduction

HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care

Mpox outbreak in Australia: half of cases had previously received a vaccine

Gilead announces plans to support generic lenacapavir for low-income countries

WHO situation report on mpox

Major update of UK PrEP guidelines online for public consultation

NICE defers decision on CAB-LA as PrEP needing more information

Second lenacapavir PrEP study protected 99.9% of people in the PURPOSE 2 trial: ACT UP London challenge pricing

UNAIDS reports debt crisis obstructs HIV response

i-Base library archived at the Bishopsgate Institute and Wellcome Collection

New HIV drug interactions, statin resource and free hybrid workshop

UK orders 150,000 doses of MVA-BN mpox vaccine

ART, weight changes and obesity: results from CASCADE cohort

Activist pin-up calendar from ACT UP London

AIDS 2024: Including people living with HIV in non-HIV research

New guidelines for HIV-related lymphoma

Responses to mpox clade 1b emergency: webinar details

IAS 2024: Open letter to IAS over online access

WHO declares new mpox emergency (clade 1b): tecovirimat not effective in DRC study

AIDS 2024: Ten early reports

BMS to discontinue atazanavir/cobicistat (Evotaz) in September 2024

Five days on two days off: Biktarvy in pilot FOTO study

Subcutaneous formulation of long-acting CAB/RPV discontinued

First data on third-generation integrase inhibitor from ViiV

Switching to daily oral bictegravir and lenacapavir dual therapy to simplify ART in ARTISTRY-1 study

AIDS 2024: Lenacapavir as PrEP is “beyond wonderful” but PURPOSE 1 study tells us so much more 

Low efficacy and high price of dapivirine ring: not included as PrEP in South African guidelines

Semaglutide in people with HIV: reduces both central and peripheral fat worsening lipoatrophy

Lenacapavir could be produced for $40 a year: 1000-fold lower than current US price for treating MDR HIV

Updated WHO guidelines for HIV PEP (July 2024)

AIDS 2024: Introduction to AIDS 2024

UNAIDS report: The urgency of now – AIDS at a crossroads.

New community call to challenge social settings that drive HIV-related stigma

HIV research to watch out for at the AIDS 2024 conference

CHAI six-monthly market report (July 2024)

New US screening guidelines to reduce risk of anal cancer in people living with HIV

HIV pipeline: global overview for people in LMICs

i-Base printed resources: please order now while stocks last

Lenacapavir PrEP: 100% efficacy in cisgender women sets new challenges for global pricing and access

CHIVA resources for children living with HIV

CROI 2024 final reports: statins, doxy-PEP and TAF implant

Doxy-PEP studies at CROI 2024

HIV and statins: REPRIEVE studies at CROI 2024

European guidelines on statins in people living with HIV (EACS 2024)

Challenges with annual TAF implant

New CDC guidelines recommend selected use of doxy-PEP in the US (2024)

“Let’s talk about sex work”: A terminology statement and guide

Post navigation